Elevance Health, Inc.: dividend

ELVNYSEHealthcare · Hospital & Medical Service Plans

Price

$429.69

November 13, 2026Market cap $94.8B

What Ploutos Investor adds for Elevance Health

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Yield

1.60%

$6.87 per share over the last 12 months, at a price of $429.69.

Forward yield1.60%($1.72 a quarter)

FCF coverThe year's free cash flow was 4.3 times the dividend it paid.
4.3x
Payout29% of the last 12 months' earnings went to the dividend.
29%
No cutWithout a cut since 2011, the first year of our figures: the run may be longer.
14+
5-year growthAverage yearly growth over the last five years.
+12.2%
Debt / EBITDAMoney that goes to interest does not go to the dividend.
-0.7x

The dividend year by year

What it paid per share each fiscal year, how much that changed, and the yield it gave at the price at year end.

+12.2% a year over 5 years
  • 2025
    Dividend per share$6.84
  • 2024
    Dividend per share$6.52
  • 2023
    Dividend per share$5.92

Each fiscal year's dividend as the company states it in its filings, adjusted for stock splits. Special dividends count in the year they were paid.

The dividend year by year

ELV's dividend per share each fiscal year, from 2009 to 2022, 14 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Everything it returns to shareholders

The dividend is one way. The other is buybacks, which reduce the number of shares.

Dividend yield

1.60%

$16.00 a year per $1,000 of shares

Buybacks

2.75%

$27.50 a year per $1,000 of shares

The share count fell by 2.9% over the year.

Total returned

4.35%

$43.50 a year per $1,000 of shares

dividend 37%buybacks 63%

ELV beside the other dividend payers

Where it stands among this week's 968 dividend payers, and in the Healthcare sector. The dot is the company, the white line the median.

Dividend yield1.60%

Above 40% of the payers · median 2.03%

In Healthcare: above 66%, median 0.93%.

Covered by free cash flow4.3x

Above 60% of the payers · median 3.6x

In Healthcare: above 45%, median 4.4x.

Dividend growth, 5 years+12.2%

Above 84% of the payers · median +6.3%

In Healthcare: above 83%, median +5.8%.

Share of earnings paid out29%

Above 40% of the payers · median 35%

In Healthcare: above 56%, median 25%.

Yield, cover and years without a cut for almost 1,000 stocks, in one table.The table

The full analysis

What do Elevance Health's filings show?

The dividend is one part of Elevance Health's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about ELV's dividend

Didn't find what you were looking for?

Ask us
What is ELV's dividend yield?

Elevance Health paid $6.87 per share over the last 12 months. At a price of $429.69, that is a yield of 1.60%.

Does ELV cover its dividend with the cash it makes?

Yes, over the last year. Elevance Health's free cash flow was 4.3 times the dividend it paid.

Has ELV ever cut its dividend?

Elevance Health has not cut its dividend for 14+ years, in the 15 years of figures we hold.

How much has ELV's dividend grown?

Elevance Health's dividend per share changed by +12.2% a year on average over the last five years.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.